Gel aims to stop surgical bleeding in kidney cancer operations
NCT ID NCT07284953
Summary
This study planned to test a special gel called PuraBond that helps stop bleeding during kidney cancer surgery. The gel forms a protective barrier when applied to surgical wounds. The trial was withdrawn before any patients were enrolled, so no results are available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Royal Wolverhampton NHS Trust
Wolverhampton, WV10 0QP, United Kingdom
Conditions
Explore the condition pages connected to this study.